These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 1740481)
21. Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption. Schlemmer A; Hassager C Eur J Endocrinol; 1999 Apr; 140(4):332-7. PubMed ID: 10097253 [TBL] [Abstract][Full Text] [Related]
22. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women. Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002 [TBL] [Abstract][Full Text] [Related]
23. A longitudinal study of bone-related biochemical changes at the menopause. Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654 [TBL] [Abstract][Full Text] [Related]
24. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk]. Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382 [TBL] [Abstract][Full Text] [Related]
25. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women. Uretmen S; Gol M; Cimrin D; Irmak E Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419 [TBL] [Abstract][Full Text] [Related]
26. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070 [TBL] [Abstract][Full Text] [Related]
27. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. Delmas PD; Schlemmer A; Gineyts E; Riis B; Christiansen C J Bone Miner Res; 1991 Jun; 6(6):639-44. PubMed ID: 1887826 [TBL] [Abstract][Full Text] [Related]
28. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416 [TBL] [Abstract][Full Text] [Related]
29. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. Kushida K; Takahashi M; Kawana K; Inoue T J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Eastell R; Robins SP; Colwell T; Assiri AM; Riggs BL; Russell RG Osteoporos Int; 1993 Sep; 3(5):255-60. PubMed ID: 8400607 [TBL] [Abstract][Full Text] [Related]
31. Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin. Sairanen S; Tähtelä R; Laitinen K; Karonen SL; Välimäki MJ Calcif Tissue Int; 1994 Nov; 55(5):349-52. PubMed ID: 7866915 [TBL] [Abstract][Full Text] [Related]
32. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women. Tsai KS; Ebeling PR; Riggs BL J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989 [TBL] [Abstract][Full Text] [Related]
33. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy. Greenspan SL; Holland S; Maitland-Ramsey L; Poku M; Freeman A; Yuan W; Kher U; Gertz B Proc Assoc Am Physicians; 1996 May; 108(3):230-8. PubMed ID: 8774056 [TBL] [Abstract][Full Text] [Related]
34. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626 [TBL] [Abstract][Full Text] [Related]
35. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis. Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722 [TBL] [Abstract][Full Text] [Related]
36. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001 [TBL] [Abstract][Full Text] [Related]
37. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830 [TBL] [Abstract][Full Text] [Related]
38. The effect of calcium supplementation on the circadian rhythm of bone resorption. Blumsohn A; Herrington K; Hannon RA; Shao P; Eyre DR; Eastell R J Clin Endocrinol Metab; 1994 Sep; 79(3):730-5. PubMed ID: 8077353 [TBL] [Abstract][Full Text] [Related]
39. Circulating cytokine levels in osteoporotic and normal women. Khosla S; Peterson JM; Egan K; Jones JD; Riggs BL J Clin Endocrinol Metab; 1994 Sep; 79(3):707-11. PubMed ID: 8077350 [TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]